CDRE

AI Memo

Cadre

As of 2026-09-02/Confidence high

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-09-02 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

high

Horizon

—

Key catalyst

Raised FY2026 guidance and backlog validation • 2026-12-01

Base target: $32 / p=55% prob

Biggest risk

Acquisition integration, backlog timing, lower agency demand in distribution, foreign-exchange pressure, higher compensation and contingent-consideration expense, and recent insider selling could limit the rerating.

Invalidation

Break below $24 or thesis failure.

What would change my mind?

Strong Q2 execution, record backlog, raised FY2026 guidance, and recurring demand in law enforcement, first responder, military, and nuclear markets support a cautiously positive forward thesis.

Research note

Recommendation

—

Confidence

high

As of

2026-09-02

Base target

$32

p=55%

Bull target

$38

p=25%

Bear target

$24

p=20%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Insider-selling sentiment overhang
Record backlog conversion
Bolt-on M&A and operating-model integration

BearKey bullets

Backlog conversion, product mix, and acquisition integration may not match current guidance assumptions.
Lower agency demand for hard goods in the Distribution segment remains a disclosed demand risk.
[#SEC-8K-2026-08-05]

WatchKey bullets

Raised FY2026 guidance and backlog validation

Summary

High-level snapshot

Recommendation

Model confidence

high

Timeframe

Asset

Equity

Trigger

Base case: $32 (p=55%)

Target spread vs base: +21% / -25%

Scenario probabilities

Bull Target: $38 (p=25%)Base Target: $32 (p=55%)Bear Target: $24 (p=20%)

Commentary

Primary-source news flow is positive following strong Q2 results, a record backlog, and raised guidance. However, post-print price reaction and analyst revisions are unverified, while social, options, short-interest, and employee-sentiment data are unavailable; zero values represent missing data rather than neutral signals. The result is a cautiously bullish monitoring view rather than a high-conviction rerating thesis.

As of 2026-09-02 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Strong Q2 execution, record backlog, raised FY2026 guidance, and recurring demand in law enforcement, first responder, military, and nuclear markets support a cautiously positive forward thesis.

Bear Case

Drivers

Scannable catalysts and supporting factors

Insider-selling sentiment overhang
Record backlog conversion
Bolt-on M&A and operating-model integration

Scenarios

Bull Target (Scenario probability)

$38 / p=25% prob

Base Target (Scenario probability)

$32 / p=55% prob

Bear Target (Scenario probability)

$24 / p=20% prob

Analysis 2026-09-02 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.65

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-12-01
Raised FY2026 guidance and backlog validation
Q2 net sales grew 32% year over year, adjusted EBITDA grew 56%, backlog reached a record $368 million, and management raised FY2026 revenue and adjusted EBITDA guidance. Conversion of backlog into second-half results is the next key validation point. [#SEC-8K-2026-08-05]
Prob 85.00% • Move 5.00% • Priced-in 65.00%

Short-term Catalysts

Next few weeks

Insider-selling sentiment overhang
2026-12-01
Recent Form 4 filings show open-market sales by CEO Warren Kanders and President Brad Williams. This is a sentiment and supply risk, not direct evidence of weakening operations. [#SEC-FORM4-2026-08-26]
Prob 55% • Move -4% • Priced-in 40%

Long-term Catalysts

Months to a year

Record backlog conversion
2027-09-02
Demand across nuclear safety, armor, duty gear, and related products could support continued growth as the record backlog converts, although timing and product mix remain execution-sensitive. [#SEC-8K-2026-08-05]
Prob 75% • Move 9% • Priced-in 45%
Bolt-on M&A and operating-model integration
2027-09-02
Alien Gear and other complementary acquisitions may broaden Cadre’s platform and support scale benefits, but integration and acquisition execution remain unproven forward variables. [#8-K-2026-08-05]
Prob 65% • Move 7% • Priced-in 35%

Risks

Backlog conversion, product mix, and acquisition integration may not match current guidance assumptions.
Lower agency demand for hard goods in the Distribution segment remains a disclosed demand risk. [#SEC-8K-2026-08-05]
Net income declined year over year in Q2 and the first half despite higher sales and adjusted EBITDA, partly due to contingent-consideration expense, compensation expense, and adverse foreign exchange. [#SEC-8K-2026-08-05]
Recent open-market sales by senior insiders may create a near-term sentiment or share-supply overhang. [#SEC-FORM4-2026-08-26]
Verified post-earnings market reaction, analyst revisions, options positioning, short interest, social sentiment, and employee sentiment are unavailable.

Peers

Symbol	Summary
ROCK	Similar-size capital-goods company, but industrial and renewable exposure makes it only a broad sector reference rather than a direct safety-equipment comparable.
GBX	Similar-market-cap capital-goods candidate, but rail-equipment exposure and end-market risks differ materially from Cadre’s mission-critical safety platform.
EMR	Large diversified automation and controls company; useful for broad industrial context but a weak direct valuation peer because of scale and business mix.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-09-02

Loading AI feed…

Symbol

Summary

ROCK

Similar-size capital-goods company, but industrial and renewable exposure makes it only a broad sector reference rather than a direct safety-equipment comparable.

GBX

Similar-market-cap capital-goods candidate, but rail-equipment exposure and end-market risks differ materially from Cadre’s mission-critical safety platform.

EMR

Large diversified automation and controls company; useful for broad industrial context but a weak direct valuation peer because of scale and business mix.